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Abstract
Background: The aim of this study was to evaluate the number of women who take multivitamin formulations containing iodine.
Material and methods: A 34-question questionnaire was given to 500 women during their puerperal stay in two obstetrics/gynaecology 
wards in Krakow. 
Results: 295 pregnant women (59%) took iodine-containing formulations. 205 pregnant women (41%) took multivitamin preparations 
without iodine. 49.7% of the women (91 out of 183) who inhabited rural areas and small towns were not supplemented with iodine during 
pregnancy. Women in Krakow took iodine-containing multivitamin formulations in 61.2% of cases. Women with primary and secondary 
education did not use iodine supplementation in 48.3% and 50.3% of cases respectively. Women with a university education did not use 
supplementation in 38.6% of cases. The prevalence of women using iodine-containing multivitamin preparation was similar in each age 
group.
Conclusions: The promotion of iodine supplementation to pregnant women should be augmented at each level of contact with medical 
staff. Medical staff should be reminded about such promotion at each level of medical care and training (general practitioner, obstetrics/gyn-
aecology specialist, endocrinologist, postgraduate training). (Pol J Endocrinol 2011; 62 (4): 309–315)
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Streszczenie
Wstęp: Celem pracy była ocena liczby kobiet w ciąży stosujących preparaty witaminowe zawierające jod.
Materiał i metody: Badanie ankietowe przeprowadzono u kolejnych 500 kobiet, które urodziły dzieci w latach 2007–2008 na dwóch 
oddziałach położniczych w Krakowie Nowej Hucie. Ankietę składającą się z 34 pytań przeprowadzano w czasie pobytu pacjentek na 
oddziałach położniczych pomiędzy 2. a 4. dniem połogu. 
Wyniki: Spośród badanych 295 pacjentek (59%) przyjmowało w ciąży preparaty witaminowe zawierające rekomendowaną dawkę jodu, 
natomiast 205 ciężarnych (41%) stosowało preparaty witaminowe pozbawione jodu. W przypadku ciężarnych zamieszkujących tereny 
wiejskie i małe miasta (n = 183) 91 kobiet (49,7%) nie stosowało w ciąży suplementacji jodu. Odsetek ten ulegał korzystnemu odwróceniu 
w przypadku mieszkanek Krakowa (n = 317), gdzie 38,8% ciężarnych nie przyjmowało preparatów zawierających rekomendowaną dawkę 
jodu. Podobnie wysoki odsetek pacjentek, które przyjmowały preparaty bez jodu dotyczył kobiet z wykształceniem zawodowym (48,4%) 
i średnim (50,3%). Kobiety z wykształceniem wyższym w 38,6% przypadków nie stosowały preparatów zawierających jod. W każdym 
z przedziałów wiekowych przeważały pacjentki przyjmujące preparaty z rekomendowaną dawką jodu.
Wnioski: Istnieje konieczność zwiększenia edukacji kobiet w ciąży dotyczącej konieczności dodatkowej suplementacji jodem na wszystkich 
poziomach opieki zdrowotnej: lekarza pierwszego kontaktu, położnika i ginekologa, endokrynologa oraz w szkoleniu podyplomowym. 
(Endokrynol Pol 2011; 62 (4): 309–315)
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Introduction
Iodine has been identified by the World Health Organisa-
tion as one of the factors influencing health status. Iodine, 
which is a trace element and does not accumulate in the 
body, has to be supplemented. Excessive iodine is excreted 
in the urine [1]. Seafish and seafood generally, spring water, 
and air with droplets of sea water are extremely richsources 
of iodine. Iodised salt is the primary food source of iodine at 
a population level [2]. The implementation of a population 
strategy for preventing iodine deficiency by introducing 
iodised salt and an extra iodine supplementation in selected 
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groups resulted, over the course of 14 years, in a decrease in 
the number of countries with iodine deficiency as a national 
public health problem, from 110 in 1993 to 47 in 2007 [3]. 
Delange in 2002 reported that 32 European countries were 
affected by iodine deficiency in the early 1990s [4]. The 
same article says that access to iodised salt at the household 
level in European countries increased from 5% in 1990 to 
28% in 1999 [4]. 
During pregnancy and lactation, the daily require-
ment for iodine increases nearly twofold due to en-
hanced renal clearance of iodine, iodine trapping by 
the placental-fetal unit, and increased release of hepatic 
thyroid binding globulin. Insufficient iodine intake can 
result in decreased production of thyroid hormones and 
hypothyroidism. Maternal hypothyroidism frequently 
leads to foetal brain damage [5]. In 2006, the American 
Thyroid Association recommended that all women 
should receive 150 μg iodine in addition to their regular 
dietary intake during pregnancy and lactation [5]. 
In the Polish strategy of iodine prophylaxis, an ad-
ditional daily intake of 150–200 μg iodine as medication 
is strongly recommended during pregnancy and lacta-
tion after evaluating the dietary habits of pregnant and 
breastfeeding women [6]. In 2003, Poland was rated by 
WHO and ICCIDD as belonging to the group of coun-
tries (roughly one third of Europe’s population) where 
iodine intake is sufficient at a population level [7–9]. 
Because household salt is the main carrier of iodine in 
the Polish model of iodine prophylaxis. and because 
mean individual salt consumption in Poland is at least 
double the recommended WHO level, current efforts 
aimed at preventing iodine deficiency aim to increase 
consumption of non-salt iodine-rich products (e.g. 
milk and mineral water). Once they achieve an iodine 
concentration of 0.1–0.2 mg, these products can easily 
supplement any decrease in physiological iodine levels 
resulting from reduced salt consumption [10]. 
However, the seasonal variation in iodine concentra-
tion in these products should be taken into considera-
tion. Brzóska et al. studied iodine concentration in Polish 
consumer milk. Iodine concentration for provincial 
cities ranged from 63.8 to 173.7 mg/L. Compared to the 
winter, milk iodine concentration in the summer was 
lower by an average of 25.2%, with standard deviations 
of between 4.3% (Kielce) and 52.2% (Wrocław) [11]. 
Wide-ranging educational campaigns, to be coordinated 
by the newly designated WHO Collaborating Centre for 
Nutrition at the Chair of Endocrinology at Jagiellonian 
University, are also required [10].
At the International Council for the Control of Iodine 
Deficiency Disorders (ICCIDD) Conference held in Istan-
bul in 2004, it was revealed that in pregnant women iodine 
intake frequently falls below the recommended level of 200 
μg. This is the result of non-compliance with the regimen 
of additional iodine intake during pregnancy and lactation. 
In Europe, the additional daily dose of iodine is 100–150 μg 
taken as a supplement to the regular diet of pregnant and 
breastfeeding women. The World Health Organisation 
(WHO) recently increased its recommended iodine intake 
during pregnancy from 200 to 250 μg/day [12]. 
The aim of this study was to verify (via a question-
naire survey) the number of pregnant patients who took 
iodine-containing multivitamin preparations amount-
ing to not less than 150 μg of iodine daily. 
Material and methods
An anonymous questionnaire survey was given to 500 
consecutive women who gave birth in2007 and 2008 
in two obstetric wards in Krakow Nowa Huta. The 
questionnaire included 34 questions and was given to 
postpartum mothers during their stay in the obstetric 
wards, on the second, third or fourth  day after delivery. 
The mothers were asked which brand of multivitamin 
preparation was taken by them during pregnancy. 
Those who took preparations with at least 150 μg of 
iodine daily (in one tablet or as a simultaneous intake 
of vitamin preparations with at least a 150 μg iodine 
tablet) were considered as sufficiently supplemented. 
The staff who distributed the questionnaires were al-
lowed to explain a question if necessary, but those actu-
ally conducting the analysis did not come into contact 
with the patients. 
All questionnaires were analysed and then divided 
according to where the patient lived, their education, 
age, and number of pregnancies. The questionnaire can 
be found in Appendix 1. 
Statistical analysis 
Due to the characteristics of the gathered data, propor-
tion test was employed to determine the differences 
between specific groups. In Tables I to IX, a p-value is 
given for the weakest difference only, i.e. the greatest 
p-value obtained from all pairs possible.
Results
The majority (57.4%) of women were aged 21 to 30 years, 
and the smallest group was of those aged over 40 (3%, 
p < 0.01) (Table I). Most of the respondents lived in 
a voivodeship capital (64.4%) and only 8% (the smallest 
group) in a county capital (p < 0.001) (Table II). Most 
were university graduates (51.4%, p < 0.001), and most 
had just given birth to their first child (55.4%, p < 0.001) 
(Tables III and IV).
The results of the questionnaire survey carried out 
in 500 consecutive women who gave birth in 2007 and 
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Table I. The division of patients included in the study according to age group 
Tabela I. Liczba pacjentek biorących udział w badaniu w poszczególnych przedziałach wiekowych
Age group ≤ 20 yrs 21–30 yrs 31–39 yrs Above 40 yrs p
Number of patients
Ratio 
33 
6.6%
287 
57.4%
165 
33%
15 
3%
< 0.01
Table II. The division of patients included in the study according to dwelling place
Tabela II. Miejsce zamieszkania pacjentek biorących udział w badaniu
Dwelling place Countryside Small town County town Voivodship city p
Number of patients
Ratio
95
19%
43
8.6%
40
8%
322
64.4%
< 0.001
B/C NS
Table III. The division of patients included in the study according to their education
Tabela III. Wykształcenie pacjentek biorących udział w badaniu
Education Primary Secondary Higher p
Number of patients
Ratio
73
14.6%
170
34%
257
51.4%
< 0.001
Table IV. The division of patients included in the study according to number of past pregnancies
Tabela IV. Podział pacjentek ze względu na liczbę przebytych ciąż
Number of past pregnancies Primagravida Multipara p
Number of patients
Ratio
277
55.4%
223
44.6%
< 0.001
Table V. The number of patients who took multivitamin preparations containing at least 150 μg of iodine 
Tabela V. Liczba pacjentek zażywających w ciąży preparaty bez jodu i preparaty z jodem w dawce nie mniejszej niż 150 μg
Type of preparation Without iodine With iodine p
Number of patients
Ratio
205 
41%
295
59%
< 0.001
Table VI. The number of patients who took multivitamin preparations containing at least 150 μg of iodine in particular age 
groups
Tabela VI. Liczba pacjentek zażywających preparaty bez jodu i preparaty z jodem w dawce nie mniejszej niż 150 μg, 
w poszczególnych przedziałach wiekowych
Age group
Type of preparation
≤ 20 yrs 21–30 yrs 31–39 yrs Above 40 yrs p
Without iodine 16 (7.8%) 117 (57.1%) 64 (31.2%) 8 (3.9%) < 0.001; B/C NS
With iodine 17 (5.8%) 170 (57.6%) 101 (34.2%) 7 (2.4%) < 0.05
p NS NS NS NS
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Table VII. The division of patients who took multivitamin preparations containing at least 150 μg of iodine according to 
their dwelling place
Tabela VII. Liczba pacjentek zażywających preparaty bez jodu i preparaty z jodem w dawce nie mniejszej niż 150 μg w zależności 
od miejsca zamieszkania
Dwelling place
Type of preparation
Countryside Small town County town Voivodship city p
Without iodine 47 (22.9%) 19 (9.3%) 17 (8.3%) 122 (59.5%) < 0.001; B/C NS
With iodine 48 (16.3%) 24 (8.1%) 23 (7.8%) 200 (67.8) < 0.005; B/C NS
p NS NS NS NS
Table VIII. The division of patients who took multivitamin preparations containing at least 150 μg of iodine according to 
their education
Tabela VIII. Liczba pacjentek zażywających preparaty bez jodu i preparaty z jodem w dawce nie mniejszej niż 150 μg 
w zależności od stopnia wykształcenia badanych
Education
Type of preparation
Primary Secondary Higher p
Without iodine 31 (15.1%) 67 (32.7%) 107 (52.2%) < 0.001
Without iodine 42 (14.2%) 103 (34.9%) 150 (50.9) < 0.001
NS NS NS
Table IX. The division of patients who took multivitamin preparations containing at least 150 μg of iodine according to the 
number of past pregnancies
Tabela IX. Liczba pacjentek zażywających preparaty bez jodu i preparaty z jodem w dawce nie mniejszej niż 150 μg w zależności 
od liczby ciąż
Number of past pregnancies
Type of preparation
Primagravida Multipara p
Without iodine 114 91 < 0.05
With iodine 163 132 < 0.01
p NS NS
2008 in two obstetric wards in Krakow-Nowa Huta 
showed that more than a third of these women (41%) 
during pregnancy did not reach the recommended dose 
of iodine, although most (59%; p < 0.001) had done so 
(Table V). Iodine-containing multivitamin preparations 
were most frequently used in the group of women aged 
21–30 (Table VI). Pregnant women aged under 20 and 
over 40, in 48.5% and 53.3% of cases, respectively, did 
not supplement their diet with iodine. Urban dwellers 
were more likely to take vitamin preparations. The 
inhabitants of rural areas in 49.5% of cases took mul-
tivitamin preparations which did not contain the 
recommended amount of iodine (Table VII). Women 
who were university graduates most commonly were 
able to adequately supplement their diet with iodine 
(Table VIII). Women who had just had their first child 
more frequently supplemented their diet with iodine 
than did those women who had given birth previously 
(Table IX).
Discussion
Despite strong recommendations from both domestic 
and international authorities that the diet of pregnant 
and lactating women should be supplemented with 
150 μg, or even 250 μg, daily doses of iodine, 41% of 
the inhabitants of Krakow and its vicinity did not take 
the proper amount of iodine. A study carried out in 
Sydney showed moderate to severe iodine deficiency 
in pregnant and lactating women in recent years 
[13]. The authors suggested that it was necessary to 
promote iodine supplementation in pregnant women 
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in this population [13]. In another Australian survey, 
the results of which were published at the beginning 
of 2010 and which was carried out in a group of 139 
pregnant women, it was shown that only 35% of them 
took iodine-containing multivitamin preparations, 11% 
changed their diet intentionally to increase their iodine 
intake, and only just over half of the women (51–58%) 
knew which foods were rich in iodine [14]. 
A Spanish study carried out in Valencia in a group 
of 232 pregnant women demonstrated that 60.8% 
of them used iodised salt and 51.3% of them used 
iodine-containing multivitamin preparations [15]. 
A Norwegian survey of 40,108 pregnant women re-
vealed that 31% of them supplemented their diet with 
vitamins, although the dietary intake of iodine did 
not reach the Nordic Recommendations for pregnant 
women. [16]. Another Spanish report, this time from 
Barcelona, should however be mentioned: in a group 
of 1,844 pregnant women from an iodine-sufficient 
population, supplementation with an iodine-contain-
ing multivitamin preparation resulted in lowering the 
blood level of free thyroxine in the second trimester 
of pregnancy [17]. A very recent Spanish study of 
1,522 women showed that 48.9% of Valencian women 
consumed iodine supplements, 93.3% in Gipuzkoa, 
and 11.0% in Sabadell. The prevalence of iodised salt 
consumption was 50.5% in the whole sample. The uri-
nary iodine concentration reached the WHO reference 
levels only in Gipuzkoa, where iodine supplements 
were widely consumed [18]. 
Hashemipour et al. in a cross-sectional study 
compared urinary iodine concentrations (UIC) in 
newborns with congenital hypothyroidism, as well 
as UIC and the milk iodine concentrations (MIC) of 
their mothers to a control group [19]. They found 
that iodine excess could be a possible risk factor for 
congenital hypothyroidism, but there were findings, 
such as a lack of correlation between maternal MIC 
and UIC, and the median neonatal UIC, which was 
similar in the two groups [19]. Keshteli et al. excluded 
the role of zinc status in the high prevalence of goitre 
in the Isfahan region [20]. 
Ołtarzewski and Szymborski carried out their re-
search in the 1990s, in a Polish population, on a much 
larger group than ours. They showed a similar percent-
age (47.7%) of pregnant women who did not supple-
ment their iodine intake properly [7]. Studies on the 
Krakow population carried out in the 1980s and 1990s 
revealed that 80% of pregnant women had goitre and 
abnormal ioduria if they did not supplement their io-
dine intake properly [21].
Conclusions
The promotion of iodine supplementation should be 
augmented at each level of contact medical staff have 
with pregnant women. Medical staff must be reminded 
about such promotion at each level of medical care and 
training (general practitioner, obstetrics/gynaecology 
specialist, endocrinologist, postgraduate training).
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1. Age: . . . . . . . . 
2. Dwelling place
 6 voivodeship capital
 6 poviat capital
 6 gmina capital
 6 rural area
3. Education:
 6 primary school
 6 basic vocational school
 6 secondary school (general)
 6 secondary school (technical)
 6 college
 6 university (B.A.)
 6 university (M.A.)
4. Profile of education:
 6 secondary school, biomedical profile (e.g. nursery school, 
medical laboratory technician school, emergency medi-
cal technician school, dental technician school, general 
secondary school with biological-chemical profile)
 6 secondary school, mathematical profile (e.g. school of 
commerce, school of economics, general secondary 
school with mathematical-physical profile)
 6 secondary school, another profile
 6 university, biomedical profile (e.g. medicine, nursery, 
veterinary, medical emergency, medical laboratory 
analytics, pharmacy, biology, biotechnology, Agricultural 
University of Krakow)
 6 university, mathematical profile (e.g. economics, tech-
nical, mathematics, physics, Krakow University of 
Economics, AGH University of Science and Technology, 
Krakow University of Technology, Faculties of Math-
ematics, Physics etc. of the Jagiellonian University)
 6 university, humanistic profile (e.g. philosophy, sociology, 
psychology, pedagogy, philologies)
 6 university, other profile
5. Have you been diagnosed with a chronic disease?
 6 diabetes mellitus
 6 hypertension
 6 hypothyroidism
 6 other thyroid diseases (please specify) . . . . . . . . . . . . . . .
 6 other chronic diseases (please specify) . . . . . . . . . . . . . . .
6.  Was the last pregnancy:
 6 your first (then skip to question 10)
 6 subsequent (which one) 
7.  How did the past pregnancies finish?
 6 miscarriage (which pregnancy and which week)
 6 preterm delivery (which pregnancy and which week)
Appendix: questionnaire
 6 delivery at term (37–40 week) (which pregnancy and 
which week)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 post-term delivery (which pregnancy and how many 
days after the term)  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8. Past normal pregnancies finished with:
 6 vaginal delivery (e.g. 1st pregnancy, vaginal delivery)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 caesarean section (e.g. 2nd pregnancy, caesarean sec-
tion). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9. Children born previously are:
 6 healthy (which pregnancy)
 6 congenitally defected (which pregnancy)
 6 affected with cerebral palsy resulting from perineal 
complications (which pregnancy) 
 6 others  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10. Did the last pregnancy develop normally? 
 6 Yes
 6 No
11. If no, did any of the following symptoms occur? 
(please select all that apply and give the number 
of weeks they occurred for the first time and when 
they disappeared)
 6 vaginal bleeding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 premature cramps of uterus . . . . . . . . . . . . . . . . . . . . . . . .
 6 premature rupture of the membranes . . . . . . . . . . . . . . .
 6 oedema. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 proteinuria. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 vomiting. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 anaemia  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
 6 others — please specify . . . . . . . . . . . . . . . . . . . . . . . . . . . .
12. How much weight did you gain during pregnancy?
 6 less than 10 kg
 6 10–15 kg
 6 15 kg or more
13. In which week of pregnancy was your child born?
. . . . . .
14. The last pregnancy finished with:
 6 vaginal delivery 
 6 caesarean section 
15. The last child was born as:
 6 healthy
 6 congenitally defected (please specify)  . . . . . . . . . . . . . . .
 6 affected with cerebral palsy
 6 others  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
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16. How many points did the neonate score in the Apgar 
scale? Please give the length and weight of the child.
Apgar score . . . . . .
Birth weight . . . . . .
Birth length . . . . . .
17. Did you take any multivitamin preparations during 
the last pregnancy?
 6 Yes
 6 No
18. Did you take any prenatal multivitamin preparations 
during the last pregnancy?
 6 Yes
 6 No
19.  From which week of pregnancy did you start taking 
multivitamin preparations? 
From . . . . . week of the pregnancy
20. Who recommended that you take multivitamin 
preparations in pregnancy?
 6 husband
 6 mother
 6 mother in law
 6 sister
 6 friend
 6 your doctor
 6 another patient
21. Did you take any vitamin preparations shortly 
before the pregnancy?
 6 Yes
 6 No
22. Did you take vitamin preparations and folic acid 
simultaneously in pregnancy?
 6 Yes
 6 No
23. Did you take vitamin preparations and folic acid 
simultaneously before your pregnancy?
 6 Yes
 6 No
24. Did you take singular folic acid supplements 
during the whole period of pregnancy? 
 6 Yes
 6 No
25. Did you take singular folic acid supplements before 
your pregnancy?
 6 Yes
 6 No
26. After the third month of pregnancy, were you 
advised to stop taking folic acid and start multivita-
min preparations? 
 6 Yes
 6 No
27. After the third month of pregnancy, who recom-
mended that you stop taking folic acid and start 
multivitamin preparations?
 6 husband
 6 mother
 6 mother in law
 6 sister
 6 friend
 6 your doctor
 6 another patient
28. Which multivitamin preparations did you take 
in pregnancy?
 6 Feminatal 
 6 Feminatal N
 6 Prenatal classic
 6 Prenatal complex
 6 Materna
 6 Centrum Materna
 6 Vitrum Prenatal
 6 Elevit
 6 Falvit
 6 Falvit M
 6 Folik
 6 Jodid
 6 Jodex
 6 other (please specify) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
29. Did you replace the multivitamin preparation with 
another one during the last pregnancy?
 6 Yes
 6 No
30. What was the reason for changing one preparation 
to another in the last pregnancy?
 6 recommendation of relatives
 6 recommendation of a friend
 6 recommendation of the doctor
 6 recommendation of other patients
 6 side effects
31. After the previous pregnancy, did you take any 
multivitamin preparations during lactation?
 6 Yes
 6 No
